Irene Cuppari: Whole Blood and Component Therapy in Traumatic Hemorrhage
Irene Cuppari, Director of Transfusion Medicine Service ASST Ovest Milanese, shared Blood Transfusion Journal‘s post on LinkedIn about a recent article she and her colleagues co-authored, published in BT, adding:
“I am pleased to share this Commentary recently published in Blood Transfusion, focused on the use of whole blood in the treatment of traumatic hemorrhage in the prehospital setting.
The recent SWiFT and TOWAR trials represent an important milestone, as they introduce phase 3 randomized evidence in a field that has so far been supported mainly by observational data and physiological rationale.
The message that emerges is clear, though not definitive: whole blood did not demonstrate superiority over component therapy in the prehospital strategies evaluated, but this should not be interpreted as evidence of equivalence or non-inferiority.
A crucial methodological and organizational debate therefore remains open: every transfusion strategy should be assessed not only in terms of clinical effectiveness, but also with regard to sustainability, appropriateness, accessibility, and impact on transfusion services.
Many thanks to my co-authors Daniele Prati, Luca Barcella, and Chiara Novelli for this collaborative work.”
Blood Transfusion Journal shared a post on LinkedIn:
“New Publication Alert
We’ve just published a new article: ‘Prehospital whole blood after SWiFT and TOWAR: not superior, not settled’, focusing on Transfusion Medicine.”
Title: Prehospital whole blood after SWiFT and TOWAR: not superior, not settled
Authors: Daniele Prati, Luca Barcella, Chiara Novelli, Irene Cuppari
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 13, 2026, 15:39Ritu Verma: Recognizing Deep Vein Thrombosis Before Complications Arise
-
Jun 13, 2026, 15:09Akshat Jain: Does Mitapivat Translate to Clinical Benefit in SCD?
-
Jun 13, 2026, 14:58Olga Benítez Hidalgo: New Evidence on Marstacimab in Hemophilia Care
-
Jun 13, 2026, 14:52Sophie Georgin-Lavialle: First ERN-RITA Recommendations on USAID
-
Jun 13, 2026, 14:48Andrew Jackson: Personalized Approaches to Catheter-Related Thrombosis Prevention
-
Jun 13, 2026, 14:45Ghazaleh Bankefors: Reconnecting Across Borders and Decades at EHA 2026
-
Jun 13, 2026, 14:41Tom Langenaeken: Targeting Factor XI in Mechanical Heart Valve Thrombosis
-
Jun 13, 2026, 14:36Heghine Khachatryan: Pregnancy, Thrombosis, and Aspirin – Who Really Needs Prophylaxis?
-
Jun 13, 2026, 14:24Thomas Stauch: ITP Therapeutics Enter a New Era of Targeted Treatment